Cargando…
Concurrent hypereosinophilic syndrome and deep vein thrombosis after Pfizer‐BioNTech COVID‐19 vaccination: A case report
Herein, we report a case of eosinophilia syndrome and deep vein thrombosis presenting concurrently after the administration of the BNT162b2 mRNA‐based coronavirus disease 2019 (COVID‐19) vaccine. It is extremely rare to have both hypereosinophilic syndrome and deep vein thrombosis simultaneously. Bo...
Autores principales: | Yano, Shungo, Miyagami, Taiju, Furusaka, Takayuki, Kano, Nagamasa, Naito, Toshio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9979965/ https://www.ncbi.nlm.nih.gov/pubmed/36873062 http://dx.doi.org/10.1002/ccr3.7001 |
Ejemplares similares
-
Venous sinus thrombosis after the first dose of Pfizer BioNTech vaccine
por: Qureshi, Muhammad Imran Ahmad, et al.
Publicado: (2022) -
Portal vein thrombosis after second Pfizer/BioNTech coronavirus disease 2019 vaccine
por: Petrochko, Jameson M., et al.
Publicado: (2022) -
Myocarditis with Pfizer-BioNTech's COVID-19 vaccine in Israel
Publicado: (2021) -
Thrombocytopenia with Pfizer-BioNTech or Moderna COVID-19 vaccines
Publicado: (2021) -
Pfizer-BioNTech COVID-19 vaccine safe in children
Publicado: (2022)